Conferences

American Society for Radiation Oncology (ASTRO) 2020

American Society for Radiation Oncology (ASTRO) 2020

October 2020, Virtual Oral Presentation: Results of a Randomized, Open Label, Multicenter Trial Assessing the Safety, Dose and Schedule of RRx-001 (R001) in Reducing Severe Oral Mucositis (SOM) in Patients Receiving Chemoradiation (CRT) for Oral Cavity/oropharynx...

read more
Society for Neuro-Oncology (SNO) 2018

Society for Neuro-Oncology (SNO) 2018

November 2018, New Orleans, Louisiana Abstract: Initial clinical and advanced imaging outcomes from a multi-institutional phase 1 dose-escalation trial of RRx-001 plus whole brain radiation for patients with brain metastases

read more
15th International Symposium on Anti-Angiogenic Therapy 2013

15th International Symposium on Anti-Angiogenic Therapy 2013

January 2013, La Jolla, California Abstract: Antivascular activity of RRx-001 in SCCVII and U87 tumors Abstract: RRx-001: A novel hypoxia activated nitric oxide generating vascular disrupting agent (VDA) Abstract: Preliminary results from an ongoing phase I trial of...

read more